Medical Device & IVD Blog

Complete guide to validating Electronic Data Capture (EDC) systems for medical device clinical trials — 21 CFR Part 11 compliance, EU GMP Annex 11, ICH E6(R2)/(R3) GCP requirements, GAMP 5 risk-based validation approach, IQ/OQ/PQ methodology, audit trail requirements, ALCOA+ principles, vendor vs sponsor responsibilities, study-specific validation, and common FDA inspection findings.

Complete guide to electronic Instructions for Use (eIFU) for medical devices — EU Implementing Regulation 2021/2226 as amended by Regulation 2025/1234 expanding eIFU to all professional-use devices, risk assessment requirements, labeling obligations, EUDAMED UDI integration, FDA electronic IFU policy under 21 CFR Part 801, paper IFU fallback rules, IVDR provisions for IVDs, SaMD-specific guidance, validation expectations, and implementation checklist.

How much does it cost to register a medical device in the European Union in 2026? A buyer-side breakdown of EU Authorized Representative (EC REP) service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for MDR and IVDR portfolios.

How to perform Fault Tree Analysis under ISO 14971 for medical devices — FTA vs FMEA comparison, AND/OR gate logic, quantitative probability calculations, real-world examples, and when top-down analysis outperforms bottom-up methods.

Complete comparison of hazard analysis methods for medical device risk management — when to use FMEA, FTA, PHA, HAZOP, and use-related risk analysis under ISO 14971, IEC 62366, FDA, and EU MDR requirements, with examples and decision guidance.

Hong Kong medical device registration in 2026: USD 6,000–18,000 over 3 years for MD Class II / IVD B and USD 9,000–40,000 for Class III–IV / IVD C–D under voluntary MDACS — entirely LRP service fees, since government fees are zero. Pure Global flat fee from USD 2,000/year. Hourly, reg+annual, and flat-fee models compared with 3-year cash flow, switching playbook, and Medical Device Bill transition coverage.

Complete guide to registering medical devices in Hong Kong — MDACS voluntary listing process, LRP requirements, GHTF/IMDRF classification (Class I–IV, IVD Class A–D), reference country pathways, Stage C mandatory procurement rules effective March 2026, upcoming Centre for Medical Products Regulation, timeline, fees, and transition strategy.

How much does it cost to register a medical device in Indonesia in 2026? A buyer-side breakdown of Indonesia Local Authorized Representative (LAR) service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for AKD/AKL devices and the 2% importation fee mechanic.

How medical device companies can implement ISO 27001 for information security — ISMS requirements, certification cost and timeline, integration with ISO 13485 and FDA cybersecurity requirements, IEC 62443 comparison, and step-by-step implementation roadmap.

Comprehensive guide to ISO/TR 24971:2020, the companion technical report to ISO 14971:2019 — how to use its annexes for hazard identification, risk analysis methods, benefit-risk analysis, cybersecurity, IVDs, and practical implementation across your risk management process.

Step-by-step guide to creating a compliant literature search protocol for medical device clinical evaluation under EU MDR Article 61 and Annex XIV — MEDDEV 2.7/1 Rev. 4 methodology, PICO framework, database selection, inclusion/exclusion criteria, critical appraisal, PRISMA documentation, and Notified Body expectations.

How much does it cost to register a medical device in Malaysia in 2026? A buyer-side breakdown of Malaysia Authorized Representative (MAR) service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for Class A/B and Class C/D devices, plus the CAB-MDA-MAR three-fee structure decoded.

Complete guide to medical device distribution agreements — regulatory clauses, EU MDR Article 14 importer obligations, FDA initial distributor requirements, exclusivity and territory provisions, PMS and vigilance obligations, quality agreements, and negotiation strategies for medtech manufacturers.

Complete guide to Medicare National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) for medical device manufacturers — how each process works, evidence requirements, timelines, the new RAPID pathway, Coverage with Evidence Development, MAC jurisdictions, and practical strategies for securing Medicare coverage.

Pure Global publishes Mexico MRH service at $2,000/year flat for Class I and $3,000/year for Class II/III — versus $15,000–$30,000 Year 1 under hourly billing. A buyer-side breakdown of Mexico Registration Holder (MRH) pricing models with 3-year cash flow scenarios, switching playbook, and RFP template for COFEPRIS submissions and the Equivalence Pathway.

Complete guide to registering medical devices in New Zealand — Medsafe WAND database notification process, sponsor requirements, GHTF classification, adverse event reporting, labeling obligations, TTMRA mutual recognition with Australia, and practical timeline and cost estimates for market entry.

Complete guide to CMS New Technology Add-On Payment (NTAP) for medical device manufacturers — eligibility criteria (newness, cost, substantial clinical improvement), traditional vs alternative pathways, FY 2027 application timeline, MEARIS submission, Town Hall process, payment calculation, and proposed changes to Breakthrough Device fast-track pathways.

Complete guide to registering medical devices in Pakistan — DRAP Medical Devices Rules 2017, four-tier A/B/C/D classification system, establishment licensing, online e-service portal launched July 2025, authorized representative requirements, dossier preparation, registration fees, labeling in English and Urdu, adverse event reporting, post-market surveillance, and practical timeline and cost estimates.

Guide to selecting, validating, and using patient-reported outcome (PRO) instruments in medical device clinical trials — FDA CDRH draft guidance on fit-for-purpose PROs, EU MDR clinical evaluation requirements, COA types (PRO, ClinRO, ObsRO, PerfO), instrument validation, endpoint hierarchy, and regulatory submission strategies.

Clear guide to the differences between a risk management file and risk management report under ISO 14971:2019 — what each contains, how they relate, traceability requirements, and common audit findings from notified bodies and FDA.